The tier answers “what did the studies show”; the badge answers “does the mechanism agree with physics.” For this device the two answers differ — no controlled trial has tested the claim, so it is not refuted, yet the proposed mechanism contradicts established physics. The atlas no longer conflates the two.
A canonical physically-incoherent claim: a pathogen-specific 'mortal oscillatory rate' that selectively kills. The RF generator is ordinary hardware; the selective-lethal-resonance claim contradicts physics.
Rife machines belong to the Information / Bioresonance / Biofield family as one of its founding “frequency” claims. The central idea is a pathogen- or tumor-specific “mortal oscillatory rate” — a frequency that selectively shatters the target while leaving healthy tissue untouched. It is the canonical physically-incoherent claim of the atlas: a real radio-frequency generator wrapped around a mechanism that contradicts physics.
The keep half is thin but worth stating precisely. A Rife device is an RF generator — ordinary, reusable electronics that genuinely produce radio-frequency output. That hardware is real in the same trivial sense that any signal generator is real. What it is not is the thing claimed. And it must not be confused with legitimate cousins that use known dosimetry to deliver energy to tissue: RF hyperthermia, ablation, and tumor-treating fields (TTFields) are established, dosed modalities with defined mechanisms. The Rife claim borrows their surface vocabulary — frequency, resonance, cells — without their physics.
The mechanism fails before any trial is needed. A pathogen is on the order of a micrometre; the RF wavelengths invoked are on the order of metres — roughly a million-fold scale mismatch between the “resonator” and the wave meant to resonate it. No selective lethal-resonance mechanism exists by which a field would identify one organism and mechanically destroy it while sparing its surroundings. So the grade is F: not “awaiting evidence” but contradicted by established electromagnetics. The clinical record matches the physics — no credible evidence of benefit, promoters have faced fraud actions, and UK cancer charities state plainly that these devices do not cure cancer. The shared Lancet Oncology review of unconventional cancer devices is the cited source; beyond it, the case rests on first-principles physics rather than on a literature, because there is no supporting literature to weigh.
Rife sits in the Not supported by evidence-based science tier on the contradicts-established-science axis — the sub-badge for claims that are physically incoherent rather than merely untested. Keep the axes separate. The hardware is real (an RF generator exists and functions); the plausibility of the therapeutic claim is nil (the scale mismatch is fatal); the grade is F (contradicted). A working signal generator does not lend any support to the cure claim built on top of it. This is the opposite situation from a tested-not-confirmed device, where a real measurement still awaits a valid reading — here the claimed effect is ruled out at the level of mechanism.
There is no clearance anywhere to read as efficacy. In the US the devices are not FDA-approved and promoters have faced fraud actions. In the EU they are not CE-marked as medical devices. In Russia they are unregulated; in China not approved; in Australia not listed. The market — Spooky2, GB4000, Rife Digital, and Chinese export “analyzers” in the roughly $100–3,000 range — runs entirely outside medical authorisation. The absence of any registration here is not a regulatory gap to be filled; it is consistent with a claim that has no validated mechanism to register.
The line traces to Royal Raymond Rife in the United States in the 1920s–30s and was revived decades later by a succession of builders. It is a distinctly American root of the “frequency medicine” current charted on the lineage page, a sibling in spirit to the broadband-oscillator claims of the electromagnetic family. What recurs across the pattern is the same move seen throughout this family: real, reusable electronics presented as a targeted therapeutic field it cannot be.
Keep: the RF generator as ordinary electronics, and the sharp boundary that separates it from the legitimate, dosed cousins — RF hyperthermia, ablation, TTFields — which should never be tarred with the Rife claim. Set aside: the “mortal oscillatory rate” itself — selective lethal resonance on pathogens or tumors contradicts established electromagnetics, fails on the scale argument alone, and has no credible clinical support.
Registration or clearance is a market-access fact, never proof of efficacy.
| US — FDA | Not FDA-approved; promoters faced fraud actions. |
|---|---|
| EU — MDR | Not CE as a medical device. |
| Russia | Unregulated. |
| China — NMPA | Not approved. |
| Australia — TGA | Not listed. |